Juli Rifà

1.5k total citations
36 papers, 1.2k citations indexed

About

Juli Rifà is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Juli Rifà has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 11 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Juli Rifà's work include Pancreatic and Hepatic Oncology Research (10 papers), Pancreatitis Pathology and Treatment (5 papers) and HER2/EGFR in Cancer Research (4 papers). Juli Rifà is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Pancreatitis Pathology and Treatment (5 papers) and HER2/EGFR in Cancer Research (4 papers). Juli Rifà collaborates with scholars based in Spain, United States and Vietnam. Juli Rifà's co-authors include Núria Malats, Miquel Porta, Francisco X. Real, Alfredo Carrato, Luisa Guarner, Isabel Bover, Josep Lluís Piñol, P. Viladiu, Vı́ctor Moreno and E Canals and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Juli Rifà

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juli Rifà Spain 17 602 262 240 237 196 36 1.2k
G. R. Howe Canada 12 437 0.7× 240 0.9× 128 0.5× 294 1.2× 154 0.8× 19 1.5k
Barbara Mason New Zealand 21 393 0.7× 162 0.6× 289 1.2× 116 0.5× 278 1.4× 36 2.4k
Jane C. Schroeder United States 29 795 1.3× 491 1.9× 248 1.0× 232 1.0× 565 2.9× 52 2.3k
F.E. van Leeuwen Netherlands 21 292 0.5× 516 2.0× 180 0.8× 149 0.6× 227 1.2× 45 1.7k
Giedrė Smailytė Lithuania 19 547 0.9× 151 0.6× 246 1.0× 297 1.3× 232 1.2× 121 1.2k
Libby M. Morimoto United States 20 938 1.6× 270 1.0× 139 0.6× 244 1.0× 414 2.1× 68 1.7k
Ronald K. Ross United States 10 391 0.6× 112 0.4× 177 0.7× 163 0.7× 226 1.2× 11 1.3k
Michael N. Passarelli United States 18 642 1.1× 208 0.8× 152 0.6× 232 1.0× 223 1.1× 55 1.3k
Silke Kropp Germany 26 711 1.2× 427 1.6× 108 0.5× 236 1.0× 607 3.1× 33 1.9k
Ru‐Nie Gao Canada 15 387 0.6× 169 0.6× 181 0.8× 230 1.0× 180 0.9× 22 1.1k

Countries citing papers authored by Juli Rifà

Since Specialization
Citations

This map shows the geographic impact of Juli Rifà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juli Rifà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juli Rifà more than expected).

Fields of papers citing papers by Juli Rifà

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juli Rifà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juli Rifà. The network helps show where Juli Rifà may publish in the future.

Co-authorship network of co-authors of Juli Rifà

This figure shows the co-authorship network connecting the top 25 collaborators of Juli Rifà. A scholar is included among the top collaborators of Juli Rifà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juli Rifà. Juli Rifà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Lucy Anne, Miquel Porta, Blanca Lumbreras, et al.. (2011). Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. European Journal of Epidemiology. 26(3). 229–236. 14 indexed citations
2.
López–Pousa, Antonio, et al.. (2010). Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours. European Journal of Cancer Care. 19(5). 648–655. 29 indexed citations
3.
Crous‐Bou, Marta, Miquel Porta, Tomás López‐Jiménez, et al.. (2009). Lifetime history of alcohol consumption and K‐ras mutations in pancreatic ductal adenocarcinoma. Environmental and Molecular Mutagenesis. 50(5). 421–430. 7 indexed citations
4.
Porta, Miquel, José Pumarega, Manel Jariod, et al.. (2009). In pancreatic ductal adenocarcinoma blood concentrations of some organochlorine compounds and coffee intake are independently associated with KRAS mutations. Mutagenesis. 24(6). 513–521. 14 indexed citations
5.
Morales, Eva, Miquel Porta, Jesús Vioqué, et al.. (2007). Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. Journal of Epidemiology & Community Health. 61(7). 641–649. 24 indexed citations
6.
Rueda, Antonio, P. Sabín, Juli Rifà, et al.. (2007). R‐CHOP‐14 in patients with diffuse large B‐cell lymphoma younger than 70 years: a multicentre, prospective study. Hematological Oncology. 26(1). 27–32. 13 indexed citations
7.
Colomer, Rámón, Antonio Llombart‐Cussac, Ignasi Tusquets, et al.. (2006). Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain. Clinical & Translational Oncology. 8(12). 896–902. 9 indexed citations
8.
González-Martı́n, Antonio, Isabel Bover, María Jesús Rubio, et al.. (2005). Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study. Annals of Oncology. 16(5). 749–755. 90 indexed citations
9.
Molina, Rafael, Xavier Filella, Rafael Fuentes, et al.. (2003). Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis. Tumor Biology. 24(4). 209–218. 232 indexed citations
10.
Llobera, Joan, et al.. (2003). Quality of life for oncology patients during the terminal period. Validation of the HRCA-QL index. Supportive Care in Cancer. 11(5). 294–303. 11 indexed citations
11.
Porta, Miquel, Sergi G. Costafreda, Núria Malats, et al.. (2000). Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. European Journal of Epidemiology. 16(6). 533–541. 34 indexed citations
12.
Llobera, Joan, Magdalena Esteva, Juli Rifà, et al.. (2000). Terminal cancer. European Journal of Cancer. 36(16). 2036–2043. 124 indexed citations
13.
Alguacil, Juan, Miquel Porta, Fernando G. Benavides, et al.. (2000). Occupation and pancreatic cancer in Spain: a case-control study based on job titles. International Journal of Epidemiology. 29(6). 1004–1013. 36 indexed citations
14.
Muro, Xavier García del, Catalina Vadell, G. Pérez Manga, et al.. (1998). Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis. European Journal of Cancer. 34(1). 193–195. 17 indexed citations
15.
Malats, Núria, Miquel Porta, Josep M. Corominas, et al.. (1997). Ki-ras mutations in exocrine pancreatic cancer: Association with clinico-pathological characteristics and with tobacco and alcohol consumption. International Journal of Cancer. 70(6). 661–667. 54 indexed citations
16.
Porta, Miquel, Núria Malats, Josep Lluís Piñol, Francisco X. Real, & Juli Rifà. (1996). Response. Journal of Clinical Epidemiology. 49(5). 602–603. 8 indexed citations
17.
Malats, Núria, Miquel Porta, Josep Lluís Piñol, et al.. (1995). Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.. Journal of Clinical Oncology. 13(7). 1679–1686. 41 indexed citations
18.
19.
Garau, Isabel, Enric Benito, F. Xavier Bosch, et al.. (1994). Blood transfusion has no effect on colorectal cancer survival. A population-based study. European Journal of Cancer. 30(6). 759–764. 16 indexed citations
20.
Porta, Miquel, Núria Malats, Josep Lluís Piñol, et al.. (1994). Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. Journal of Clinical Epidemiology. 47(9). 1069–1079. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. R. Howe Breakdown of academic impact, for papers by Barbara Mason Breakdown of academic impact, for papers by Jane C. Schroeder Breakdown of academic impact, for papers by F.E. van Leeuwen Breakdown of academic impact, for papers by Giedrė Smailytė Breakdown of academic impact, for papers by Libby M. Morimoto Breakdown of academic impact, for papers by Ronald K. Ross Breakdown of academic impact, for papers by Michael N. Passarelli Breakdown of academic impact, for papers by Silke Kropp Breakdown of academic impact, for papers by Ru‐Nie Gao
Rankless by CCL
2026